5/6/2023 0 Comments Genmark diagnostics![]() operates as a subsidiary of Roche Holding AG. As of April 21, 2021, GenMark Diagnostics, Inc. ![]() ![]() The company currently operates in one reportable business segment, which encompasses the development, manufacturing, sales, and support of instruments. The company was incorporated in 2010 and is based in Carlsbad, California. GenMark Diagnostics Inc is a provider of automated, multiplex molecular diagnostic testing systems that detect and measure DNA and RNA targets to diagnose disease and optimize patient treatment. was formerly known as Osmetech plc and changed its name to GenMark Diagnostics, Inc. The goal for the development program was. The company serves customers through distributors. GenMarks ePlex System is a state-of-the-art sample-to-answer molecular diagnostic test for infectious diseases. It offers ePlex systems to streamline the diagnostic workflow from physician order entry to the release of the final report, automate and accelerate order entry and results reporting, notify practitioners that test results are available, enable operation on every shift, minimize system downtime and ensure patients and physicians have access to rapid test results, and reduce avoidable medical errors ePlex software to support the needs of laboratory and healthcare systems, streamline tasks across the diagnostic process from order-to-report, improve productivity at every level, improve order-to-report turnaround time, reduce labor costs, and eliminate potential transcription errors with bi-directional LIS capabilities XT-8 systems for processing multiple tests ePlex panels that include respiratory pathogen and blood culture identification (BCID) Panels to identify the viral and bacterial organisms associated with upper respiratory infection, provide broad coverage of organisms that can lead to sepsis along with the resistance genes, and aid clinicians in the identification of bacterial and fungal organisms and XT-8 panels to provide sensitive and specific respiratory virus detection with an optimized workflow to maximize laboratory efficiency. designs and manufactures multiplex molecular diagnostic solutions to enhance patient care, improve quality metrics, and reduce the total cost-of-care for laboratory professionals, healthcare providers, and customers in the United States and internationally. GenMark Diagnostics overall culture is rated B based on 137 ratings from 12 GenMark Diagnostics employees. Roche and GenMark Diagnostics announced that they have entered into a definitive merger agreement for Roche to fully acquire GenMark at a price of US 24.05.
0 Comments
Leave a Reply. |